CARDIAC TOXICITY
Clinical trials for CARDIAC TOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIAC TOXICITY trials appear
Sign up with your email to follow new studies for CARDIAC TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer survivors may finally ditch heart pills: major trial underway
Disease control Recruiting nowThis study looks at whether cancer survivors who had heart problems from their cancer treatment can safely stop taking heart failure medications once their heart function is back to normal. About 335 adults who have finished cancer therapy and are on heart medications will be ran…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE4 • Sponsor: Dinesh Thavendiranathan • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Heart shield: statins may keep cancer therapy on track
Disease control Recruiting nowThis study tests whether taking a daily statin (atorvastatin) can prevent heart damage caused by HER2-targeted therapy in women with early-stage breast cancer. About 60 participants will take the statin alongside their cancer treatment. The goal is to reduce treatment delays or e…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC